Santa Barbara, CA, United States of America

Kathryn Kamath

This inventor holds 16 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 1 EPO patent, primarily in Biotechnology Innovations. Top assignees: Cytomx Therapeutics, Inc., University of California. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kathryn Kamath. Retrieved from https://idiyas.com/inventor/kathryn-kamath

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 8)

% Patents Active = 87.5

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 6.4

ph-index = 13

Forward Citations = 622(Granted Patents)

Company Filing History:

16 out of 94

Cytomx Therapeutics, Inc.

patents

6 out of 16,048

University of California

patents

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

Areas of Expertise:

Activatable Antibodies

Binding Polypeptides

Proproteins

Matrix Metalloprotease

Anti-VEGF

Anti-EGFR

Cleavable Peptides

Interferon Alpha

Modified Antibody Compositions

Methods of Treatment

Identification Methods

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12209120 - Activatable anti-VEGF scFv (2025-01-28),

2. 11028162 - Methods for manufacturing activatable binding polypeptides comprising matrix metalloprotease cleavable moieties (2021-06-08),

3. 10875913 - Methods of treatment using activatable anti-EGFR antibodies (2020-12-29),

4. 10513549 - Cleavage-activatable interferon-alpha proprotein (2019-12-24),

5. 10118961 - Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV (2018-11-06),

6. 10077300 - Activatable binding polypeptides and methods of identification and use thereof (2018-09-18),

7. 10059762 - Anti-EGFR activatable antibodies (2018-08-28),

8. 9644016 - Soluble notch receptor proproteins and methods of use thereof (2017-05-09),

9. 9453078 - Modified antibody compositions, methods of making and using thereof (2016-09-27),

10. 9169321 - Activatable binding polypeptides and methods of identification and use thereof (2015-10-27),

11. 8993266 - Proproteins activatable interferon alpha (2015-03-31),

12. 8563269 - Modified antibody compositions, methods of making and using thereof (2013-10-22),

13. 8529898 - Activatable binding polypeptides and methods of identification and use thereof (2013-09-10),

14. 8518404 - Activatable binding polypeptides and methods of identification and use thereof (2013-08-27),

15. 8513390 - Modified antibody compositions, methods of making and using thereof (2013-08-20),

Title: The Innovative Journey of Kathryn Kamath

Introduction: Kathryn Kamath, a pioneering inventor based in Santa Barbara, CA, has made significant contributions to the field of technology with her groundbreaking innovations.

Latest Patents: Kathryn Kamath's latest patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time.

Career Highlights: With a career spanning over two decades, Kathryn Kamath has established herself as a leading figure in the tech world, with a focus on developing solutions that enhance people's lives.

Collaborations: Throughout her career, Kathryn Kamath has collaborated with top research institutions and universities to bring her inventions to life, showcasing her dedication to pushing the boundaries of technology.

Conclusion: Kathryn Kamath's relentless pursuit of innovation and her passion for creating impactful solutions solidify her position as a trailblazing inventor in the tech industry.

Profile summary based on public USPTO records.